Continue reading below for a detailed analysis of the latest technology development from GNOM Complete Genomics in the next-generation sequencing landscape, from our friend Dale Yuzuki, an industry professional and blogger at www.yuzuki.org.
The next catalyst awaiting GNOM is submission of their application very shortly in order to become a CLIA-certified laboratory, a key achievement for targeting the clinical genome sequencing market.
Disclosures for the author and editor: None.
The next catalyst awaiting GNOM is submission of their application very shortly in order to become a CLIA-certified laboratory, a key achievement for targeting the clinical genome sequencing market.
Disclosures for the author and editor: None.
RSS Feed
